MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 84 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,139,000 | +37.4% | 472,056 | 0.0% | 1.27% | +118.0% |
| Q2 2022 | $2,285,000 | -48.2% | 472,056 | 0.0% | 0.58% | -36.7% |
| Q1 2022 | $4,414,000 | -11.4% | 472,056 | +12.6% | 0.92% | +9.1% |
| Q4 2021 | $4,982,000 | +4.4% | 419,324 | 0.0% | 0.84% | +131.2% |
| Q3 2021 | $4,772,000 | -36.6% | 419,324 | 0.0% | 0.36% | +30.8% |
| Q2 2021 | $7,523,000 | +3.6% | 419,324 | -10.7% | 0.28% | +3.0% |
| Q1 2021 | $7,265,000 | +26.9% | 469,324 | -0.0% | 0.27% | -7.8% |
| Q4 2020 | $5,726,000 | -5.1% | 469,374 | 0.0% | 0.29% | -10.1% |
| Q3 2020 | $6,031,000 | – | 469,374 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,145,337 | $17,269,963 | 7.70% |
| Bleichroeder LP | 1,872,463 | $15,073,327 | 3.72% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,204,942 | $41,899,783 | 2.26% |
| Opaleye Management Inc. | 584,000 | $4,701,200 | 1.53% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $11,520,017 | 1.29% |
| Cormorant Asset Management, LP | 2,625,000 | $21,131,250 | 1.23% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 290,000 | $2,337,400 | 0.79% |
| Ikarian Capital, LLC | 746,069 | $6,005,856 | 0.72% |
| Eventide Asset Management | 4,529,997 | $36,466,476 | 0.66% |
| Altium Capital Management LP | 125,033 | $1,006,516 | 0.52% |